What Post-Approval Studies Mean for Alzheimer’s Drugs
Post-approval studies confirm whether Alzheimer's drugs work in real patients—and can result in withdrawal if trials fail to prove benefit.
Category Tools
How Daily Function Measures Shape Dementia Drug Approvals
Daily function measures like CDR-SB and ADAS-Cog are the regulatory currency that determines which dementia drugs get FDA approval.
Can Families Help Track Alzheimer’s Treatment Effects?
Families observe treatment changes doctors miss between appointments—tracking at home can guide medication decisions when documented systematically.
Can Families Help Track Alzheimer’s Treatment Effects?
Families observe daily patterns that doctors can't—if they track changes systematically, those observations shape how Alzheimer's treatments are adjusted.
Why Passive Monitoring Raises Privacy Concerns
Passive monitoring technology reveals intimate patterns of behavior, but most people don't realize what data is collected or who can access it.
Could Wearables Detect Early Dementia Patterns?
Your smartwatch may notice walking, sleep, and routine changes years before a memory test would. Here's what the research shows.
How Smartphones Could Help Monitor Memory Changes
Smartphones can track memory changes through regular cognitive tests and behavioral metrics, helping people spot decline early—but they're not a diagnosis tool, and limitations are real.
Can Digital Tests Track Cognitive Decline at Home?
Home cognitive apps can track changes in processing speed and memory, but they're not designed to diagnose dementia or catch all meaningful cognitive decline.
What Families Should Know About AI Dementia Tools
AI tools can now detect dementia earlier and support caregivers in real time—but families need to understand their real benefits, limits, and privacy risks.
Could Testing Tools Miss Dementia in Some Communities?
Yes, standard dementia testing tools can and do miss dementia in some communities. The most widely used cognitive screening instruments, including the...